ENDRA Life Sciences (NASDAQ:NDRA) reported quarterly losses of $(0.05) per share which met the analyst consensus estimate. This is a 16.67 percent increase over losses of $(0.06) per share from the same period last year.
Pool Corp Q2 Earnings Miss Estimates Amid Macro Woes; Cuts FY23 EPS Outlook
Pool Corporation (NASDAQ: POOL) reported a second-quarter FY23 sales decline of 9.7% year-on-year to $1.857 billion,